Procainamide

Procan SR

500 MG Tablet (Extended-Release)CanadaCancelledAuthorised 31 Dec 1985

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Procan SRUnited States · 1GM, 250MG, 500MG … · tablet, extended release · ParkedaleSame brand
ProcanUnited States · 250MG, 375MG, 500MG · capsule · Parke DavisSame brand
Procainamide HydrochlorideUnited States · 1GM, 250MG, 500MG … · tablet, extended release · Watson LabsSame form
ProcamideBrazil · Zambon Laboratórios Farmacêuticos Ltda.Same substance
Biocoryl 100 MG/ML Solucion InyectableSpain · 1000 mg · solución inyectable · Mana Pharma S.L.Same substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Procainamide

Procan SR

500 MG Tablet (Extended-Release)CanadaCancelledAuthorised 31 Dec 1985

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Procainamide
Strength: 500 MG
Dosage form: Tablet (Extended-Release)
Route: Oral
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1985
Registration: DIN 00638676
Marketing authorisation holder: Erfa Canada 2012 INC
ATC code: C01BA02
Group: Cardiovascular system
Supply: PRESCRIPTION

Apo-Procainamide Cap 375MGProcainamide · 375 G · CapsuleCanadaCancelled

Apo-Procainamide Cap 500MGProcainamide · 500 MG · CapsuleCanadaCancelled

Procainamide-250 Cap 250MGProcainamide · 250 MG · CapsuleCanadaCancelled

Procainamide-375 Cap 375MGProcainamide · 375 MG · CapsuleCanadaCancelled

Procainamide-500 Cap 500MGProcainamide · 500 MG · CapsuleCanadaCancelled

Procan SRProcainamide · 750 MG · Tablet (Extended-Release)CanadaCancelled

Procan SRProcainamide · 250 MG · Tablet (Extended-Release)CanadaCancelled

Pronestyl Cap 250MGProcainamide · 250 MG · CapsuleCanadaCancelled

Pronestyl Cap 375MGProcainamide · 375 MG · CapsuleCanadaCancelled

Pronestyl Cap 500MGProcainamide · 500 MG · CapsuleCanadaCancelled